HAL Id: hal-02725815
https://hal.inrae.fr/hal-02725815
Submitted on 2 Jun 2020HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci-entific research documents, whether they are pub-lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Changes in colonic motility induced by sennosides in
dogs: evidence of a prostaglandin mediation
G. Staumont, Jean Fioramonti, Jacques Frexinos, Lionel Bueno
To cite this version:
Changes
in
colonic motility induced by sennosides
in
dogs:
evidence of
a
prostaglandin mediation
G STAUMONT, J FIORAMONTI, J FREXINOS, AND L BUENO
From the Department of Pharmacology INRA and theDepartmentof Gastroenterology,
Rangueil
HQspital, Toulouse, FranceSUMMARY
The effects of sennosides
oncolonic motility
wereinvestigated in eight conscious
dogschronically fitted with
twostrain
gaugetransducers in the proximal
colon, anintracolonic silicone
catheter
and
apolyethylene catheter implanted
in abranch of
theright colonic
artery.Oral
sennosides (30
mg/kg)inhibited colonic motility
for 12to18 h afterathreetosix hours delay, andassociated with
giant contractions and diarrhoea. The minimal oral dose of sennosidestoproducesuch
changes varied from
5to15
mg/kg.
Intracolonicsennosides at the minimaleffectivedoseand
at 30mg/kg reproduced the effects of oral sennosides, but with
ashorter
latency(0.5-45
h).Intracolonic PGE2 (100 tg/kg) in
viscous gel medium orintra-arterial PGE2 (10/tgfh)
inhibitedcolonic
motility
andinduced
giant contractions often associated with defecation. The colonic
motor
changes induced by intracolonic sennosides
at theminimal effective
dose, but not thoseinduced by
intracolonic PGE2,
wereblockedby
intra-arterial indomethacin(10
[&g/h)
orpiroxicam
(5
[tgfh).
These results suggest thatcolonic
motoractions of
sennosides are mediated through alocal
prostaglandins synthesis, asthey wereblocked by cyclooxygenase inhibitor and reproducedby PGE2.
Sennosides, the main laxative components ofsenna
extracts, which chemically belong to the anthra-quinones,areknowntoinduce fluid secretionin the colon'2andtomodify colonic motility.-5Becauseof their dianthrone-13-glycoside structure a bacterial degradation of sennosides is necessary to obtain active laxative metabolites.6 For this reason senno-sidesarepharmacologicallyinert in the upper gastro-intestinal tract and have an action localised at the colonic level.
Theeffects of sennosides on colonic motility
re-maincontroversial: astimulationofperistaltic
pres-sure waveshas been reported in human after intra-luminal administrationthroughacolostomy3whereas
a reduction of the intracolonic pressure' and a
long lasting inhibition of the colonic myoelectrical activity4 have been described after oral administra-tion inmananddogsrespectively.These
discrepan-Address forcorrespondence: Dr J Fioramonti, Station dePharmacologie,
INRA, 180 chemin de Tournefeuille, 31300 Toulouse, France. Received forpublication11March1988.
ciesmaybeattributed to differences in methodology, the intraluminal application not being a classical routeand the electromyography technique not taking intoaccounttheamplitudeof contractions. The first aim of this study was, to describe the changes in colonic motility induced by oral administration of puresennosides in thedog,aspeciescharacterisedby
awelldefined colonic motorprofile.7
The secretory effects of sennosides have been shown to be mediated through a prostaglandin synthesis as they are blocked by indomethacin.28 Prostaglandins are also known to modify colonic motility. Prostaglandin E has been foundto induce
a persistaltic activity in isolated longitudinal strips of colon associated with a relaxation of circular muscles,9todecreasesigmoid intraluminal
pressure`
Colonic motility and sennosides
synthesis.Consequentlyattempts toblock the effects of sennosides by indomethacin and to reproduce thembyPGE2administrations were done. Because of the strong ulcerogenicaction ofindomethacin in dogs'3 and the complete inactivation of prosta-glandins by lungs,'4 indomethacin and PGE2 were locally infused through a catheter chronically in-serted inacolonic artery.
Methods
ANIMALS
Eightmongrel dogs,20-25kg inweight, were used in these experiments. Under halothane anaesthesia, a smallpolyethylene catheter(Biotrol Pharma, Paris, id 0.30 mm, od 0.70 mm) was inserted into a ramificationof the right colonic artery inthe opposite direction of the bloodstreamaccordingto atechnqiue previously described for a jejunal artery. 1' The catheter waspushed intotheartery overadistanceof about 2cmin suchawaythat thetip was located just
atthe siteofbifurcation of the artery. Itwasfixedto the artery and the mesentery with 2:0 polyester sutures (Fig. 1). The location and the size of the perfused segment was visualised by injecting metylene blue into the catheter. The location was
6-8cmfrom the ileocolonicjunctionandthe sizewas
3-5cm.
Two strain gauge transducers constructed in our
Fig.1 Representationofselective intra-arterialinfusion techniqueoncanine colon. The catheterwasintroduced
upstreamintoanarterialramificationuntil the vessel
bifurcation.
laboratory were sutured to the serosa of thecolon, oneontheperfused segment and one 10cmaborally. Eachtransducer had itsrecording axis paralleltothe transverse axis of thecolon in order to measure the contractile force of the circular musclelayer.
Asilicone catheter (Versilic ND, Verneret, Paris, id 1 mm, od 3 mm) was inserted into the colonic lumen at 3 cm from the ileocolonic junction. The free ends of the strain gauge wires, the intra-arterial and intracolonic catheters were directed subcutan-eously along the flank to emerge dorsally between the scapulas.Both catheters remained permeable for two tofourmonths.
RECORDINGS
Calibration of each strain gauge was carried out beforeimplantation. The colonicmechanical activity detected by the two transducers was recorded by connecting the strain gauges to a Wheatstone bridge amplifier(VT 2100, Vishay, France) connected to a potentiometric recorder (RK4 Rikadenki, Toshin, Japan) withapaperspeedof 1 mm/min. The motility index at each of the two colonic sites wasdetermihed by means of a quantitative computerised analysis using a microcomputer data processor (Epson HX 20)according to the technique of Hachet et al.'6 The motility index calculated by the processing system, which reported values at 60 min intervals, corres-ponded to the measurement of the area between the baseline and the contractile curve.
EXPERIMENTALPROCEDURE
The dogs were maintained in cages for recordings over 22 consecutive hours (from 830 to 630 am). Immediately after surgery the arterial catheterwas
continuously (22/24 h) perfused with a diluted heparin solution(1000 UI/ml,2ml/24 h) bymeansof
an insulin infusion pump (Syringe driver, Type MS16,PyeDynamics, Bushey,UK). Dogswerefed
once adayat900amwithamixtureof 250 g canned (Fido)and250 g dry(Royal Canine) food fordogs. The sennosides used in these experiments(a gift from Madaus &Co,Koln, WGermany)consisted of driedpurifiedsennacontaining 92% of sennosidesA
andB,5%of sennosides
A1,
C and D,3% of water. Sennosidesweregivenat astandard doseof 30mg/kg orallyorbyintracolonicroute.The minimal effective dose of sennosides was determined by 5 mg/kg successive increases froman initial dose of 5mg/kg untilaneffectoncolonic motilityappeared. Senno-side administrations were done three hours after the daily meal.Louis, MO). Intracolonic administrations of PGE2 weregiven three hours after themeal and the
intra-arterial infusion began three hours after the mealand
lasted three hours.
Attemptstoblockthemotoreffects ofintracolonic
administration of sennosidesattheminimal effective dose or of PGE2 (100 itg/kg) were carried out by intra-arterial infusion of indomethacin (Sigma, St Louis, MO) at a rate of 10 ,ug/h, piroxicam (a gift
from Pfizer, Orsay, France) at a rate of 5 pg/h. The infusions startedtwohoursbefore intracolonic
administrations of sennosides or PGE2 and lasted sevenhours. Indomethacinandpiroxicamwerealso
intra-arterially infused alone at the same rate and during the same postprandial period in each dog. Sennosidesandpiroxicamweredissolved insaline, indomethacin in a 5% solution of NaHCO3. PGE2 was dissolved in absolute ethanol (10 mg/ml) and
storedat-20°C;further dilutionsweremadeweekly
andstored at4°C. The intra-arterial infusionrateof
drugswas0*2mV/handcontrolswereperformedwith infusionsofvehicleatthesamerate.Thecontrols for the effects of intracolonic administrations of senno-sidesor PGE2were intracolonic injection of saline
(5 ml) orexcipientofPGE2gel (5 ml) respectively.
Each experimentwas doneoncein eachdogwitha
minimal interval of48hours. The location and the
permeability of the arterial catheter was checked
dailybyarapid arterial bloodinflow in the tube when itwasdisconnectedfromthepump.
STAT1ISTICALANALYSIS
The motility indexes reported each hour after senno-side or PGE2 administration (expressed in g min/h
andgivenasmean(SD))were comparedwith those
observed during the sameperiod in control studies
with administration of the respective vehicle in the
same animals. Because of variable delay for the
inhibitoryaction ofsennosidesafteroral administra-tionaperiodof colonicmotorinhibitionwasdefined as the time including consecutive hourly motility
indexeswith valueslower than30% ofmeanmotility
index determined over 10 hours after vehicle
administration. The changesincolonic motility index during this period of inhibition were expressed as percentage of control values reported at the same
time after vehicle administration. In attempts to
block the action ofsennosidesorPGE2
intracolonic-allyadministered by intra-arterial infusions of indo-methacinor piroxicam, motility indexeswere
com-pared duringaperiod comprised between three and
five hours after the beginning of thd intra-arterial infusion-that is, betweenoneand three hours after
intracolonic administration of sennosides or PGE2.
The number ofpeculiar colonic contractions
some-times associated with defecation, previously de-scribedasgiantcontractions`7wasmeasuredby visual
inspection of the records and expressed as mean
(SD).Acontractionwasconsideredasgiantwhen its
amplitudewasatleasttwotimeshigher ofthemean
amplitude of contractions during the same hourly
period in control experiments. Comparisons were
performed using a T Wilcoxon's test for paired values.
Results
CONTROL
In absence ofanytreatment, eachdogexhibitedthe typicalpatternof colonic motility alreadydescribed.7 During a period comprised between three and 13
hoursaftermeal,itconsisted of contractions grouped
inphases lasting 8.9 (2.8)min, occurringatintervals
of18.4(5.1) min (mean (SD) foreight animals)and
correspondingtoameanmotilityindex of9.3(2.7)g
min/h. Administrations of vehicle of each drug used
in thisstudydidnotsignificantly(p<0-05) modify the motility index.
EFFECTSOF SENNOSIDE ADMINISTRATIONS Oraladministration of sennosidesatadoseof 30mg/
kginducedaninhibitionofcolonicmotility lasting12 to18hoursandappearingafteradelay varying from three to six hours (Fig. 2, Table 1). Abundant
Table1 Changesinmotility index andnumberofgiantcontractionsinducedbyadministrationof oral and intracolonic sennosides and intracolonic (IC) and intra-arterial (IA)PGE2.
SennosidesperOS Intracolonicsennosides
Minimal Minimal PGE2 IC PGE2IA
Control 30mglkg effectivedose 30mg/kg effectivedose 100ag/kg 10 sg/h Motilityindex 100 15(4.7) 22(7.3) 10-3(5.9) 17(7) 13(5.2) 20(8.5)
(% control)
Giantcontractions(n) 0 10-6 (4.4) 6-8(3.8) 11-5(3.9) 5.9(2.7) 3-3(1.8) 1-9(0.9)
Values aremean(SD) fromeight dogs.Changes in motilityindex wereexpressedas the percentageofcontrolmotility indexduringthe same
Colonic motility andsennosides Control
WPJLPJJ1LLIA
[69
Sennosides 30mg/kg peros Sennosides 10mg/kg peros l l l l 2 3 4 5 6 7 8 9 10Hoursaftersennosidesadminstration
Fig.2 Changesinmechanicalactivityofthe proximal colon observedinthesamedog after oral administration ofsennosides
at30mglkg andat'the minimaleffectivedose'(10 mglkg forthisdog). They consisted ofamotorinhibitionassociated with
'giantmigratingcontractions' anddefecation.
diarrhoea always occurred four to 10 hours after sennosideadministration.Giantcontractions, lasting aboutoneminuteandwithanamplitudetwo tothree timeshigherthan thatofothercontractions appeared during this period of inhibition and were often associated with defecation. Each diarrhoeic defe-cationcorresponded to agiant contraction but each giant contractionwasnotassociated withdefecation. Theminimal effective doserequiredtoinduce these disturbances of colonic
motility
anddiarrhoeavaried between 5to 15mg/kg. The duration of the colonic inhibition after the minimal effective dose wasshorter than that induced by the dose of 30mg/kg and similarly the number ofgiant contractions was
lower(Table 1).Thereduction of themotilityindex observed after theminimaldose didnot
significantly
differ however
(p>005)
from that induced by the 30mg/kgdose(Table 1).
Intracolonicinjection of sennosides induced diar-rhoea, giant contractions and an inhibition of the basalcolonicmotilitysimilar in duration and
ampli-tudetothatobserved after oraladministrationatthe same dosage. For each dog the minimal effective dose of sennosidesintracolonicallyadministeredwas
identical to that determined after oral administra-tion. The onlydifference observed between the two routes ofadministration was a shorter delay (0.5 to 1.5 h) in theappearance ofthecolonicinhibitionafter intracolonic administration.
EFFECTS OFPGE2 ADMINISTRATION
Intracolonicadministration of PGE2 (Dinoprostone gel TM) at a dose of 100rig/kg induced changes in colonicmotilityroughly similartothat observed after intracolonicadministration of sennosides(Fig. 3).A significant (p>OO1) decrease in colonic motility index (Table 1) occurred after less than one hour and lasted two to four hours. Giant contractions appeared in six of theeight dogs used, usually with diarrhoeic defecation(five ofeight dogs).
Infusion ofPGE2intoacolonic arteryatadose of 10 jig/h for three hours reproduced the effects of
PGE2 10pg/hIA
l l l l I I
-2 -1 0 1 2 3 4 5 6 7 8
Hours
Fig. 3 Effects of PGE2 on mechanical activity ofthe proximal colon using intracolonic administration and intra-arterial (IA)
infusioninthe samedog.A motorinhibitionappearedassociatedto'giantmigrating contractions' and sometimes defecation.
their intracolonic administration. An inhibition of
similaramplitude appeared within30 minutes after
the beginning of theinfusion and lasted for one to three hours after the end of theinfusion (Table 1).
Giant contractions and diarrhoeawere observed in six of theeightdogs.
ANTAGONISM OFCOLONIC MOTOREFFECTS OF SENNOSIDES
The inhibitory effect of sennosides on colonic
motilitywassuppressed (Figs. 4,5),whentheywere introduced into the colon at the minimal effective
dose during an intra-arterial infusion of indo-methacin (10 .tg/h). The number of giant contrac-tions was significantly (p<005) reduced (Table 2) and diarrhoeicdefecation occurred inonlyone dog.
Similarly piroxicam intra-arterially infused (5
Rg/h)
abolished theinhibitoryactionof intracolonic senno-sides andsignificantly (p<005)reduced the number ofgiant contractions (Fig. 5, Table 2). The motor colonic effects of intracolonic administration of
PGE2 (100
[sg/kg)
were not modified by the intra-arterial infusion of indomethacinorpiroxicam(Fig.5, Table 2).
An intra-arterial infusion of indomethacin (10
Rg/h)
or piroxicam (5 rig/h) alone did notproduce any change of colonic motility (Fig. 5, Table2).
Discussion
Our results indicate that sennosides inhibit colonic motilityindogs and induce high amplitude contrac-tions associated with diarrhoeic defecations. They
suggest that these motor effects are mediated
throughaprostaglandin synthesisastheyareinpart
suppressed by indomethacin or piroxicam and are
reproduced by intracolonic andintra-arterial PGE2. Interpretation of the effects of intravenous administration of drugs is limited by the interaction
of severalsystemsaffecting thedrugandby unknown pharmacokinetic data of the drug at the level of
Table 2 Numberofgiant contractionsinducedbyintracolonic sennosides andPGE2 duringarterialinfusion of indomethacinorpiroxicamorof theirrespectivevehicle.
Intra-arterialinfusion (0.2 mllmin)
Vehicleof Indomethacin Vehicleof Piroxicam Intracolonic administration indomethacin (10 glh) piroxicam (5 iglh)
Sennosides(minimaleffectivedose) 53(1.8) 3.4(2.4)* 4.9(0.8) 2-9 (2.3)* PGE2(100
,ggkg)
2.0(0.8) 2.2(1.1) 1.6(0.7) 2.3(1.4)Values are mean(SD)fromeight dogs. Giantcontractions were counted for 15 hours after thebeginningof theintra-arterialinfusion.
Colonic motilityand sennosides Sennosides intracolonic10mg/kg l Diarrhoea
1Uis,025ffi
L~~A
Indomethacin 120- 100- 80- 60-Sennosides intracolonic10mg/kg IndomethacinlOpg/kgIA -2 -1 0 1 2 3 4 5 HoursFig. 4 Effects ofanintra-arterial (IA)indomethacin infusiononthe colonic motor pattern inducedbyintracolonic sennosides at the'minimaleffective dose' (MED)inthe same
dog.The motorinhibition and diarrhoeicdefecationwere suppressed and the numberofthe 'giant migrating contractions'wasreducedduring indomethacin infusion.
the target organ. The interpretation of ourresults obtained withprostaglandinsismore accurate using
an intra-arterial infusion than an intravenous administration as prostaglandins are widely distri-buted in theorganism, haveavery shorthalf life
and
no storage,and arerapidly inactivated duringasingle passage through the pulmonary circulation.'4
More-overindomethacin is knowntobehighly ulcerogenic in dogs by comparison with other animal species.'` Intra-arterial infusion of indomethacin at a low dosage avoidedgastric ulcer formation.
The changes in colonic motility induced by oral administration of sennosides are partially in
agree-ment with a previous study carried out in dogs4 showinganinhibition of colonicmotility. This study4 did not describe the giant contractions seen in our
experiments, however probably because of theuseof
an electromyographic method instead of the mea-surementof the contractile force. Thegiant
contrac-tions have beenalways describedusingstrain gauge transducers7 18 and taking into account their short duration, their detection on a colonic electromyo-gram is probably not easy. Inhibition of colonic motilityand presenceofgiantcontractions associated with defecation seem to be common features of laxative induced changes in colonic motilityasthey
were previously observed with castor oil and mag-nesium citrate. 18
Thelatency of threetosix hours between the oral administration of sennosides and the appearance of
x E (0-4,
C~
Piroxicamc120-
TI
o II 20 iicdeIA 2ml/h) Sennosides IC (med)F/e
1
SennosidesIC (med)£1
1185 PGE2 IC (lO0pg/kg) -I] mIndomethacin IA(lOpg/h) LJ or Piroxicam IA(5
pg/h) PGE2 IC (100pg/kg)Fig. 5 Comparative antagonism of intra-arterial (IA)
indomethacin andpiroxicam onchanges in colonicmotility
indexinduced by intracolonic (IC) sennosides given at the minimaleffective dose(MED) or PGE2 (100,.glkg). Values
weredetermined from one to three hours after intracolonic
administration ofsennosides or PGE2 and are mean ± SD
fromeight dogs. *Significantlydifferent(p<0-01) from values obtained with vehicle intra-arterial infusionof vehicle. Control(100%)corresponded to the motility index without any administration.
thecolonicmotordisturbancesprobably corresponds
to the orocolonic transit and was similar to that observed with otherlaxatives.'8Sennosidesareinert in the upper gastrointestinal tract,6 however, while other laxative compounds such as castor oil have been found to modify small intestinal contractile activity. ' Moreover the sennoside induced changes in colonic motility observed in dogs present some similarities with the decrease insigmoid intraluminal pressure' and the large amplitude contractions3 appearing after intraluminal application inman.
Severallaxatives20 andparticularlysennosides,2are
known to alter epithelial fluid transport resulting in netfluid accumulation. Thequestion arises whether the disturbances of colonic motility are caused by a direct action of sennosides or are aconsequenceof fluid secretion. In dogs it has been shown that infusion oflarge amounts of a hypertonic solution of mannitol did not reproduce the colonic inhibition induced by sennosides or other laxatives but onthe contrary, stimulated the basal colonic
motility.2'
On the otherhand, after oral administration ofsenno-sides in rats, the acceleration of the colonic transit preceded the net fluid secretion.22 These two data indirectly favour direct action of sennosides on
_i
colonic motility and not a consequence of fluid secretion.
Senna extracts havebeenfound to increase prosta-glandin formation in the rat colon.28 On the other hand inhibition of prostaglandin synthesis by indo-methacin has been found to antagonise the secre-toryactionof sennosides in the rat colon.2 8 Our data indicatethat the colonic motoreffects of sennosides are also mediated through a local prostaglandin synthesis.
Indomethacin inhibits fatty acid cyclo-oxygenase butalsoinhibits calciumaccumulation by mitochon-dria and microsome.23 A blockade of the effects of sennosides by indomethacin may be attributed to an inhibition ofprostaglandin synthesis but also to an action onintracellular calcium movements and it has beenshown that the actionof sennosidesonintestinal electrolyte transport was calcium dependent.' The blockade of the colonic motor effects bypiroxicam which is a cyclo-oxygenase inhibitor without action on calcium uptake,23 indicates that the sennoside induced motor effects depend upon prostaglandin synthesis. Moreover these motor effects are repro-duced byintra-arterial orintraluminal administration of PGE2. These results are not in complete agree-ment with recent data showing that intracolonic administration of PGE2 did not modify colonic transit time and did not induce diarrhoea in rats.24 Suchdiscrepancymay beattributedtodifferences in the solvant use. In the first study24 PGE2 were
dissolved in saline whereas in ourstudyPGE2 were in aviscousgel medium,usedforendocervical applica-tion25whichprobablypermittedaslow releaseofthe compoundin the colonic lumen. ThePGE2-induced inhibition of colonicmotility described herein, how-ever may be related to the relaxation of colonic circular musclereportedusingin vitro preparations9 and confirmed by the decrease in sigmoid intra-luminalpressure observed after intravenous adminis-tration of PGE2 in man.'0 Moreover, an analogy could bepointedout betweenthegiantcontractions and the PGE2-induced stimulation of peristaltic activity of isolated longitudinal strips of colon.9 Furthermore, the inhibition ofbasalcyclic contrac-tions and giant contractions seem to be a common featureof laxativesinvolvingprostaglandinsasit also appeared after castor oil administration'8 which increased colonic prostaglandin production2627 but
notafterhypertonicmannitolinfusion2'which did not modifytheprostaglandinformation.2627
Finally, our results indicate that sennosides in-duced a colonic motorpattern which mayplay a role inprostaglandinmediateddiarrhoea.
The authors thank C Betoulieres, G Bories, M Caussette,and CSantamaria for their assistance.
References
1 Donowitz M,Wicks J, Battisti L, PikeG, De Lellis R. Effect of Senokot on rat intestinal electrolyte transport. EvidenceofCa+' dependence. Gastroenterology 1984; 87:503-12.
2 Beubler E, KollarG. Stimulation ofPGE2synthesis and water andelectrolyte secretion by senna anthraquinones isinhibited byindomethacin. J PharmPharmacol1985; 37:248-51.
3 Hardcastle JD,Wilkins JL. The actionofsennQsidesand related compounds on human colon and rectum. Gut 1970; 11: 1038-42.
4 Garcia-Villar R, Leng-Peschlow E, Ruckebusch Y. Effect of antraquinone derivatives on canine and rat intestinal motility. J PharmPharmacol1980; 32:323-9.
5 WallerSL.Comparative effectof codeine and senna on motoractivity of the left colon. Gut 1975; 16:407-8. 6 Lemli J, Lemmens L. Metabolism of sennosides and
rhein in the rat.Pharmacology1980; 20(suppl 1): 50-7.
7 Fioramonti J, Bueno L. Diurnal changes in colonic motor profile in conscious dogs. Dig Dis Sci 1983; 28: 257-64.
8 Capasso F,MascoloN,AutoreG,Duraccio MR.Effect ofindomethacinonaloinand 1-8
dioxianthraquinone-induced production of prostaglandins in rat isolated colon.Prostaglandins1983;26:557-62.
9 BennettA, Fleshler B. Prostaglandins and the
gastro-intestinaltract. Gastroenterology 1970;59:790-800.
10 Hunt RH, Dilawari GB, Misiewicz JJ. The effect of
intravenousprostaglandin F2aandE2onthemotilityof
sigmoidcolon.Gut1975;16: 47-9.
11 MisiewiczJJ,WallerSL, Kiley N, Horton EW. Effect of
oralprostaglandinE1onintestinal transit inman.Lancet 1969; i: 648-51.
12 RushBD, Ruwart MJ. The roleof accelerated colonic
transit inprostaglandin-induceddiarrhoea and its
inhibi-tionbyprostacyclin.BrJPharmacol1984;83: 157-9. 13 Duggan DE, Hooke KF, Noll RM, Chiu Kwan K.
Enterohepatic circulationof indomethacin anditsrolein intestinal irritation. Biochem Pharmacol 1975; 25: 1749-54.
14 Piper PJ, VaneJR,WyllieJH. Inactivation of
prosta-glandins bythelungs.Nature1970;225:600-4.
15 Hostein J, Janssens J, Vantrappen G, Peeters TL, Vandeweerd M, Leman G. Somatostatin induces
ectopic activity fronts of the migrating motorcomplex
via alocal intestinalmechanism.Gastroenterology 1984; 87:1004-8.
16 HachetT, Bueno L, FioramontiJ,RodeC.Theuseofa compact portable microcomputer system (Epson HX
20) to measure on-line the contractile activity ofthe
digestivetractfrom8channels.Applicationto pharma-cologicaltests.JPharmacol Meth1986;16:171-80.
17 Karaus M, Sarna SK. Giant migrating contractions during defecation in the dog colon. Gastroenterology 1987;92:925-33.
18 Karaus M, Sarna SK, Ammon HV, Wienbeck M.
Effects oforallaxativesoncolonicmotorcomplexesin
dogs.Gut1987;28:1112-9.
19 StewartJJ,Bass P.Effectsofricinoleicandoleicacids
Colonic motility and sennosides 1187
20 Binder HJ. Pharmacology of laxatives. Ann Rev
PharmacolToxicol 1977; 17:355-67.
.21 FioramontiJ, Droy-Lefaix MT, Bueno L. Changesin
gastrointestinal motility induced by cholera toxin and
experimental osmotic diarrhoea in dogs: effects of treatment with an argillaceous compound. Digestion 1987; 36:230-7.
22 Leng-Peschlow E. Dual effect of orally administered
sennosidesonlarge intestinetransit and fluidabsorption in the rat. JPharm Pharmacol 1986;38:606-10.
23 Burch RM, Wise WC, Halushka PV. Prostaglandin-independent inhibition of calcium transport by non-steroidalanti-inflammatorydrugs: differential effects of
carboxylicacids andpiroxicam. JPharmacolExpTher
1983;227:84-91.
24 Leng-PeschlowE.Acceleration oflarge intestinetransit time in rats by sennosides and related compounds. JPharm Pharmacol1986;38:369-73.
25 Thiery M, Decoster JM, Parewijck W, Noah MC,
Derom R, Van Kets H. Endocervical PGE2 gel for preinduction cervical softening. Prostaglandins 1984; 27:429-39.
26 Beubler E, Juan H. Effect of ricinoleicacid andother laxatives in net water flux and prostaglandin E release by the rat colon. J Pharm Pharmacol1979;St:681-5. 27 Capasso F, Mascolo N, Autore G, Romano V.